This year promises to be a big one for health care. Cutting drug prices is a top priority for both the new Democratic House and the White House. CMS' innovation center has controversial demos in store. Obamacare is at a crossroads after a federal judge deemed the entire law invalid. Medicaid expansion and work requirements will continue to be lightning rods in statehouses and courthouses around the country. And FDA continues to crank out new policies for regulating emerging technologies.

Look Ahead 2020

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.